Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents. (Q42461352)
Jump to navigation
Jump to search
scientific article published on 24 June 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents. |
scientific article published on 24 June 2014 |
Statements
Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents (English)
Minh Truong Do
Hyung Gyun Kim